Progress with Metabolomic Blood Tests for Gastrointestinal Cancer Diagnosis-An Assessment of Biomarker Translation. (2022)
Attributed to:
Volatile hypoxia signatures in oesophageal adenocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1055-9965.epi-22-0307
PubMed Identifier: 36215181
Publication URI: http://europepmc.org/abstract/MED/36215181
Type: Journal Article/Review
Volume: 31
Parent Publication: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Issue: 12
ISSN: 1055-9965